» Articles » PMID: 10757811

Hoxa9 Immortalizes a Granulocyte-macrophage Colony-stimulating Factor-dependent Promyelocyte Capable of Biphenotypic Differentiation to Neutrophils or Macrophages, Independent of Enforced Meis Expression

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2000 Apr 11
PMID 10757811
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

The genes encoding Hoxa9 and Meis1 are transcriptionally coactivated in a subset of acute myeloid leukemia (AML) in mice. In marrow reconstitution experiments, coexpression of both genes produces rapid AML, while neither gene alone generates overt leukemia. Although Hoxa9 and Meis1 can bind DNA as heterodimers, both can also heterodimerize with Pbx proteins. Thus, while their coactivation may result from the necessity to bind promoters as heterodimers, it may also result from the necessity of altering independent biochemical pathways that cooperate to generate AML, either as monomers or as heterodimers with Pbx proteins. Here we demonstrate that constitutive expression of Hoxa9 in primary murine marrow immortalizes a late myelomonocytic progenitor, preventing it from executing terminal differentiation to granulocytes or monocytes in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) or interleukin-3. This immortalized phenotype is achieved in the absence of endogenous or exogenous Meis gene expression. The Hoxa9-immortalized progenitor exhibited a promyelocytic transcriptional profile, expressing PU.1, AML1, c-Myb, C/EBP alpha, and C/EBP epsilon as well as their target genes, the receptors for GM-CSF, G-CSF, and M-CSF and the primary granule proteins myeloperoxidase and neutrophil elastase. G-CSF obviated the differentiation block of Hoxa9, inducing neutrophilic differentiation with accompanying expression of neutrophil gelatinase B and upregulation of gp91phox. M-CSF also obviated the differentiation block, inducing monocytic differentiation with accompanying expression of the macrophage acetyl-low-density lipoprotein scavenger receptor and F4/80 antigen. Versions of Hoxa9 lacking the ANWL Pbx interaction motif (PIM) also immortalized a promyelocytic progenitor with intrinsic biphenotypic differentiation potential. Therefore, Hoxa9 evokes a cytokine-selective block in differentiation by a mechanism that does not require Meis gene expression or interaction with Pbx through the PIM.

Citing Articles

Cell Immortality: Effective Techniques to Achieve and Investigate Its Applications and Challenges.

Chalak M, Hesaraki M, Mirbahari S, Yeganeh M, Abdi S, Rajabi S Life (Basel). 2024; 14(3).

PMID: 38541741 PMC: 10971253. DOI: 10.3390/life14030417.


Defined Human Leukemic CD34+ Liquid Cultures to Study HDAC/Transcriptional Repressor Complexes.

Windisch R, Kreissig S, Wichmann C Methods Mol Biol. 2022; 2589:27-49.

PMID: 36255616 DOI: 10.1007/978-1-0716-2788-4_3.


TIFAB accelerates MLL-AF9-Induced acute myeloid leukemia through upregulation of HOXA9.

Zhao J, Xiu Y, Fu L, Dong Q, Borcherding N, Wang Y iScience. 2021; 24(12):103425.

PMID: 34877491 PMC: 8633042. DOI: 10.1016/j.isci.2021.103425.


tiRNA signaling via stress-regulated vesicle transfer in the hematopoietic niche.

Kfoury Y, Ji F, Mazzola M, Sykes D, Scherer A, Anselmo A Cell Stem Cell. 2021; 28(12):2090-2103.e9.

PMID: 34551362 PMC: 8642285. DOI: 10.1016/j.stem.2021.08.014.


HOXA9 inhibitors promote microcirculation of coronary arteries in rats via downregulating E-selectin/VCAM-1.

Liu S, Gao J, Wang S Exp Ther Med. 2021; 22(2):871.

PMID: 34194549 PMC: 8237395. DOI: 10.3892/etm.2021.10303.


References
1.
Kawagoe H, Humphries R, Blair A, Sutherland H, Hogge D . Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia. 1999; 13(5):687-98. DOI: 10.1038/sj.leu.2401410. View

2.
Wang X, Scott E, Sawyers C, Friedman A . C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. Blood. 1999; 94(2):560-71. View

3.
Thorsteinsdottir U, Krosl J, Kroon E, Haman A, Hoang T, Sauvageau G . The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells. Mol Cell Biol. 1999; 19(9):6355-66. PMC: 84606. DOI: 10.1128/MCB.19.9.6355. View

4.
Anderson K, Smith K, Perkin H, Hermanson G, Anderson C, Jolly D . PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation. Blood. 1999; 94(7):2310-8. View

5.
Blatt C, Aberdam D, Schwartz R, Sachs L . DNA rearrangement of a homeobox gene in myeloid leukaemic cells. EMBO J. 1988; 7(13):4283-90. PMC: 455142. DOI: 10.1002/j.1460-2075.1988.tb03326.x. View